("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model, today announced updates to its second quarter and full year 2025 ...

Format: Presentation and one-on-one investor meetings Presentation Time: 4:55 p.m. ET Corbus Pharmaceuticals Holdings, Inc.

ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational ...

The Securities and Exchange Commission (SEC) has been recognized as global leader in good governance for the fifth straight ...

The Securities and Exchange Commission (SEC) said Wednesday it revoked the corporate registration and financing license of ...

A financial professional and three colleagues explain the fluctuations in the 10-year Treasury bond and what investors should ...

The BC Securities Commission says a Vancouver cryptocurrency firm has been temporarily banned from trading securities and ...

The Securities and Exchange Commission (SEC) and BDO Foundation launch a partnership project to identify red flags of ...

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

Algorhythm Holdings, Inc. ( NASDAQ: RIME) Q1 2025 Earnings Conference Call May 16, 2025 10:00 AM ET Gary Atkinson – Chief Executive Officer Alex Andre – Chief Financial Officer and General Counsel ...